Skip to main content

PrestoDoctor Expands Into Michigan Ahead of New Cannabis Tax Changes

Written by Customer Service on . Posted in Public Companies.

Strategic market entry positions company for growth as Michigan prepares for 2026 tax reforms

Mesquite, NV, Oct. 21, 2025 (GLOBE NEWSWIRE) — Mesquite, NV — October 21, 2025 — Dogecoin Cash, Inc. (OTCQB: DOGP) subsidiary PrestoDoctor, a national leader in cannabis telehealth and patient-care certification services, today announced its official expansion into the State of Michigan. This move marks a significant step in the company’s strategy to grow its footprint across key regulated cannabis markets, providing telemedicine evaluations and patient-wellness services that connect licensed physicians with qualified cannabis patients statewide.

“Our mission at PrestoDoctor has always been to ensure safe, compliant, and accessible medical cannabis evaluations,” said David Tobias, CEO of Dogecoin Cash, Inc. (OTC: DOGP), parent company of PrestoDoctor. “Michigan represents both a mature and evolving market, and with the state’s regulatory and tax landscape shifting significantly, our timing could not be better to help patients and operators navigate those changes.”

Strategic Context: Rising Cannabis Taxes & Market Implications

Michigan currently imposes a 10% excise tax on recreational cannabis sales, in addition to the 6% state sales tax, for a total retail tax burden of about 16%. Beginning January 1, 2026, legislation is expected to introduce a 24% wholesale tax on cannabis products, potentially raising the effective total tax rate to one of the highest in the United States.

Economic analysts have cautioned that this additional tax burden will likely increase retail prices while dampening overall sales activity. State fiscal projections anticipate a decline in retail cannabis sales of roughly 14%, reflecting consumer price sensitivity and the challenge for operators to maintain margins in a higher-tax environment.

By contrast, medical cannabis dispensaries in Michigan do not charge the 10% excise tax that applies to recreational purchases. Medical patients pay only the standard 6% state sales tax, meaning their total tax burden is less than half that faced by recreational consumers. As the new wholesale tax takes effect, this pricing gap could make medical certifications more economically advantageous for patients—potentially renewing interest in the state’s medical cannabis program.

Tobias added, “With Michigan’s cannabis taxes set to rise sharply on January 1, 2026, the companies that prepare now—by tightening compliance systems, optimizing patient engagement, and improving digital efficiency—will be the ones that remain competitive. PrestoDoctor is here to support that transition and ensure that patients continue to have access to affordable, regulated medical cannabis care in now 20 states across the nation.”

What PrestoDoctor Brings to Michigan

  • Telehealth evaluations connecting licensed physicians with patients seeking medical cannabis certification or renewals through a secure HIPAA-compliant platform.
  • Integrated patient-management services that streamline scheduling, documentation, and follow-up care, enabling operators and physicians to focus on quality outcomes.

Why Michigan?

  • Michigan remains one of the largest cannabis markets in the U.S., generating billions in annual sales.
  • The upcoming tax increase heightens the need for efficient, technology-driven solutions that help patients and operators manage higher costs.
  • PrestoDoctor’s entry supports Michigan’s goal of strengthening the regulated marketplace and ensuring continued access to licensed medical professionals.

About PrestoDoctor

PrestoDoctor, a 51% owned subsidiary of Dogecoin Cash, Inc. (OTC: DOGP), is a leading telehealth provider specializing in medical cannabis evaluations and patient-wellness certification. The company connects patients with licensed physicians through a secure online platform, offering compliant, confidential, and convenient access to medical cannabis recommendations in multiple U.S. states.

About Dogecoin Cash, Inc. (OTCQB: DOGP)
Dogecoin Cash, Inc. is a publicly traded company with operations that include telehealth services through its subsidiary PrestoDoctor. For more information and Company disclosures, visit OTC Markets.

Investor & Media Contact
Dogecoin Cash, Inc.
Info@dogecoincashinc.com

Forward-Looking Statements: This release contains “forward-looking statements” within the meaning of federal securities laws, including statements regarding the timing, availability, scope, and expected benefits of PrestoDoctor’s services in Michigan and other markets. Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including changes in laws or regulations, operational or licensing requirements, payer and patient adoption, competitive dynamics, and other factors described in the Company’s disclosures on OTC Markets. The Company undertakes no obligation to update forward-looking statements except as required by law.

No Offer or Solicitation: This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.